According to an interview with Mandy Cohen, CDC Director, we likely reached the peak of RSV cases in December 2023, but the virus is still circulating. It’s important to remember that the majority of ...
RSV testing among infants has increased since 2015, with significant growth post-COVID-19, yet outpatient testing remains low. The study analyzed 20,752 bronchiolitis encounters across four healthcare ...
Bronchiolitis often affects infants under 2 and is usually caused by the respiratory syncytial virus (RSV). Bronchitis can happen at any age and involves inflammation due to viral infections like ...
CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...
After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on ...
Nirsevimab prophylaxis was effective against RSV-associated bronchiolitis leading to hospitalization among infants younger than 12 months of age. HealthDay News — Nirsevimab therapy effectively ...
A quarter to half of healthy infants born at term are infected with RSV in the first year of life, and 2-3% have small airway bronchiolitis and lower respiratory tract infection that requires hospital ...
With holiday parties in full gear, it's that time of year that will eventually lead to people getting sick. Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you ...
Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results